Premium
P34: SAFETY AND IMMUNOLOGICAL RESPONSE TO 300IR HOUSE DUST MITE SUBLINGUAL TABLETS IN FOUR PHASE III TRIALS
Publication year - 2018
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.34_14077
Subject(s) - medicine , sublingual immunotherapy , house dust mite , dermatology , immunology , allergy , allergen